Clinical Trials Directory

Trials / Unknown

UnknownNCT05912699

A Study to Evaluate the Effect of SlimBiotics L. Fermentum K8 Postbiotic on Weight Management and Metabolic Health Outcomes

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of SlimBiotics L. Fermentum K8 Postbiotic on Weight Management and Metabolic Health Outcomes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Slimbiotics · Unknown
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is to evaluate the efficacy of a postbiotic supplement on weight management and metabolic health. This study will be conducted as a hybrid trial consisting of both in-person visits and virtual assessments. Two groups will be included: the intervention (SlimBiotics postbiotic) and placebo. The SlimBiotics postbiotic formula is the first plant-based postbiotic targeting weight management and metabolic health. Other competing postbiotics are isolated from humans (feces) but the strains in SlimBiotics were isolated from a fermented plant (millet porridge cereal) This product contains L. fermentum K8 Postbiotic.

Conditions

Interventions

TypeNameDescription
OTHERSlimbiotics PostbioticSlimBiotics postbiotic formula contains the following ingredients: * Heat-inactivated L. fermentum K8 Postbiotic. * Microcrystalline cellulose.
OTHERPlaceboThe placebo capsules contain microcrystalline cellulose only.

Timeline

Start date
2023-07-01
Primary completion
2023-09-23
Completion
2023-09-30
First posted
2023-06-22
Last updated
2023-06-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05912699. Inclusion in this directory is not an endorsement.